Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inogen (INGN) EBITDA (2016 - 2026)

Inogen has reported EBITDA over the past 13 years, most recently at -$6.6 million for Q4 2025.

  • Quarterly EBITDA rose 49.39% to -$6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$17.0 million through Dec 2025, up 55.97% year-over-year, with the annual reading at -$17.0 million for FY2025, 55.97% up from the prior year.
  • EBITDA was -$6.6 million for Q4 2025 at Inogen, down from -$4.5 million in the prior quarter.
  • Over five years, EBITDA peaked at $12.5 million in Q3 2021 and troughed at -$56.4 million in Q4 2022.
  • The 5-year median for EBITDA is -$8.2 million (2023), against an average of -$12.4 million.
  • Year-over-year, EBITDA surged 877.76% in 2021 and then tumbled 5041.49% in 2022.
  • A 5-year view of EBITDA shows it stood at -$23.1 million in 2021, then crashed by 144.69% to -$56.4 million in 2022, then surged by 56.14% to -$24.7 million in 2023, then soared by 47.56% to -$13.0 million in 2024, then soared by 49.39% to -$6.6 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's EBITDA are -$6.6 million (Q4 2025), -$4.5 million (Q3 2025), and -$754000.0 (Q2 2025).